BIO-RAD LABORATORIES, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
BIO-RAD LABORATORIES, INC. (BIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $36.50 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $36.50M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $36.20M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $42.50M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $42.70M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $36.50M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $36.20M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $42.50M 10-K · filed 2026-02-13 |
| 2025-09-30 | $42.70M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $41.80M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $38.30M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $46.80M 10-K · filed 2025-02-14 |
| 2024-09-30 | $49.00M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $47.70M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $46.20M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $46.60M 10-K · filed 2024-02-16 |
| 2023-09-30 | $45.50M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $39.20M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $37.10M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $43.60M 10-K · filed 2023-02-17 |
| 2022-09-30 | $34.00M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $39.20M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $39.60M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $42.50M 10-K · filed 2022-02-11 |
| 2021-09-30 | $43.00M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $39.70M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $38.60M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $43.60M 10-K · filed 2021-02-16 |
| 2020-09-30 | $41.10M 10-Q · filed 2020-10-30 |
| 2019-12-31 | $41.00M 10-K · filed 2020-03-02 |